JP MORGAN/PUT/BECTON DICKINSON AND CO./210/0.1/20.09.24 Stock

Warrant

DE000JT1E8J4

Market Closed - Börse Stuttgart 03:39:29 2024-06-28 EDT
0.52 EUR +4.00% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./210/0.1/20.09.24
Current month-24.64%
Date Price Change
24-06-28 0.52 +4.00%
24-06-27 0.5 +8.70%
24-06-26 0.46 +9.52%
24-06-25 0.42 +10.53%
24-06-24 0.38 -7.32%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 03:39 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JT1E8J
ISINDE000JT1E8J4
Date issued 2024-05-31
Strike 210 $
Maturity 2024-09-20 (83 Days)
Parity 10 : 1
Emission price 0.47
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.81
Lowest since issue 0.38
Spread 0.1
Spread %17.86%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.46%
Consensus